Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Critical Care
Erschienen in: Critical Care 1/2011

01.02.2011 | Review

Bench-to-bedside review: The role of C1-esterase inhibitor in sepsis and other critical illnesses

verfasst von: Mervyn Singer, Annie M Jones

Erschienen in: Critical Care | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this bench-to-bedside review is to summarize the literature relating to complement activation in sepsis and other critical illnesses and the role of C1-esterase inhibitor (C1 INH) as a potential therapy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Rambach G, Wurzner R, Speth C: Complement: an efficient sword of innate immunity. Contrib Microbiol 2008, 15: 78-100.PubMedCrossRef
2.
McPhaden AR, Whaley K: The complement system in sepsis and trauma. Br Med Bull 1985, 41: 281-286.PubMed
3.
4.
5.
6.
7.
8.
9.
Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G: Nonallergic angioedema: role of bradykinin. Allergy 2007, 62: 842-856.PubMedCrossRef
10.
Cai S, Dole VS, Bergmeier W, Scafidi J, Feng H, Wagner DD, Davis AE: A direct role for C1 inhibitor in regulation of leukocyte adhesion. Immunol 2005, 174: 6462-6466.CrossRef
11.
Beinrohr L, Harmat V, Dobo J, Lorincz Z, Gal P, Zavodszky P: C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease. J Biol Chem 2007, 282: 21100-21109.PubMedCrossRef
12.
Landerman NS, Webster ME, Becker EL, Ratcliffe HE: Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein. J Allergy 1962, 33: 330-341.PubMedCrossRef
13.
Albrecht EA, Ward PA: Complement-induced impairment of the innate immune system during sepsis. Curr Infect Dis Rep 2005, 7: 349-354.PubMedCrossRef
14.
Monefeldt K, Helgeland K, Tollefsen T: In vitro activation of the classical pathway of complement by a streptococcal lipoteichoic acid. Oral Microbiol Immunol 1994, 9: 70-76.PubMedCrossRef
15.
Flierl MA, Rittirsch D, Nadeau BA, Day DE, Zetoune FS, Sarma JV, Huber-Lang MS, Ward PA: Functions of the complement components C3 and C5 during sepsis. FASEB J 2008, 22: 3483-3490.PubMedPubMedCentralCrossRef
16.
Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang M, Mackay CR, Zetoune FS, Gerard NP, Cianfl one K, Köhl J, Gerard C, Sarma JV, Ward PA: Functional roles for C5a receptors in sepsis. Nat Med 2008, 14: 551-557.PubMedPubMedCentralCrossRef
17.
Niederbichler AD, Hoesel LM, Westfall MV, Gao H, Ipaktchi KR, Sun L, Zetoune FS, Su GL, Arbabi S, Sarma JV, Wang SC, Hemmila MR, Ward PA: An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J Exp Med 2006, 203: 53-61.PubMedPubMedCentralCrossRef
18.
Croner RS, Lehmann TG, Fallsehr C, Herfarth C, Klar E, Kirschfink M: C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat. Microvasc Res 2004, 67: 182-191.PubMedCrossRef
19.
Schmidt W, Stenzel K, Walther A, Gebhard MM, Martin E, Schmidt H: Influence of C1-esterase inhibitor on tissue oxygenation of jejunal mucosa during endotoxemia. Int J Surg Investig 1999, 1: 277-283.PubMed
20.
Lehmann C, Birnbaum J, Lührs C, Rückbeil O, Spies C, Ziemer S, Gründling M, Pavlovic D, Usichenko T, Wendt M, Kox WJ: Effects of C1 esterase inhibitor administration on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation during experimental endotoxemia. Intensive Care Med 2004, 30: 309-314.PubMedCrossRef
21.
Fischer MB, Prodeus AP, Nicholson-Weller A, Ma M, Murrow J, Reid RR, Warren HB, Lage AL, Moore FD Jr, Rosen FS, Carroll MC: Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol 1997, 159: 976-982.PubMed
22.
Giebler R, Schmidt U, Koch S, Peters J, Scherer R: Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin. Crit Care Med 1999, 27: 597-604.PubMedCrossRef
23.
Guerrero R, Velasco F, Rodriguez M, Lopez A, Rojas R, Alvarez MA, Villalba R, Rubio V, Torres A, del Castillo D: Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor. J Clin Invest 1993, 91: 2754-2760.PubMedPubMedCentralCrossRef
24.
Jansen PM, Eisele B, de Jong IW, Chang A, Delvos U, Taylor FB Jr, Hack CE: Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. J Immunol 1998, 160: 475-484.PubMed
25.
Liu D, Cai S, Gu X, Scafidi J, Wu X, Davis AE: C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J Immunol 2003, 171: 2594-2601.PubMedCrossRef
26.
Liu D, Lu F, Qin G, Fernandes SM, Li J, Davis AE: C1 inhibitor-mediated protection from sepsis. J Immunol 2007, 179: 3966-3972.PubMedCrossRef
27.
Buerke M, Murohara T, Lefer AM: Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 1995, 91: 393-402.PubMedCrossRef
28.
Buerke M, Prufer D, Dahm M, Oelert H, Meyer J, Darius H: Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther 1998, 286: 429-438.PubMed
29.
Horstick G, Heimann A, Götze O, Hafner G, Berg O, Böhmer P, Becker P, Darius H, Rupprecht HJ, Loos M, Bhakdi S, Meyer J, Kempski O: Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation 1997, 95: 701-708.PubMedCrossRef
30.
Horstick G, Berg O, Heimann A, Götze O, Loos M, Hafner G, Bierbach B, Petersen S, Bhakdi S, Darius H, Horstick M, Meyer J, Kempski O: Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: doserelated beneficial versus detrimental effects. Circulation 2001, 104: 3125-3131.PubMedCrossRef
31.
Fu J, Lin G, Wu Z, Ceng B, Wu Y, Liang G, Qin G, Li J, Chiu I, Liu D: Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury. Biochem Biophys Res Commun 2006, 349: 504-512.PubMedCrossRef
32.
Fu J, Lin G, Zeng B, Wu Z, Wu Y, Chu H, Qin G, Liang G, Li J, Gan X, Yu X, Li C, Liu D: Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity. Biochem Biophys Res Commun 2006, 350: 162-168.PubMedCrossRef
33.
Lu F, Chauhan AK, Fernandes SM, Walsh MT, Wagner DD, Davis AE: The effect of C1 inhibitor on intestinal ischemia and reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2008, 295: G1042-1049.PubMedCrossRef
34.
35.
Niederau C, Brinsa R, Niederau M, Luthen R, Strohmeyer G, Ferrell LD: Effects of C1-esterase inhibitor in three models of acute pancreatitis. Int J Pancreatol 1995, 17: 189-196.PubMed
36.
Bhatia M, Saluja AK, Singh VP, Frossard JL, Lee HS, Bhagat L, Gerard C, Steer ML: Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 2001, 280: G974-978.PubMed
37.
Tomasdottir H, Henriksson BA, Bengtson JP, Bengtsson A, Stenqvist O, Persson H: Complement activation during liver transplantation. Transplantation 1993, 55: 799-802.PubMedCrossRef
38.
Dalmasso AP, Platt JL: Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 1993, 56: 1171-1176.PubMedCrossRef
39.
Fiane AE, Videm V, Johansen HT, Mellbye OJ, Nielsen EW, Mollnes TE: C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model. Immunopharmacology 1999, 42: 231-243.PubMedCrossRef
40.
Pöling J, Oezkur M, Kogge K, Mengel M, Niemann H, Winkler M, Haverich A, Wiebe K: Hyperacute rejection in ex vivo -perfused porcine lungs transgenic for human complement regulatory proteins. Transpl Int 2006, 19: 225-232.PubMedCrossRef
41.
Schelzig H, Simon F, Krischer C, Vogel A, Abendroth D: Ex-vivo hemoperfusion (eHPS) of pig-lungs with whole human blood: effects of complement inhibition with a soluble C1-esterase-inhibitor. Ann Transplant 2001, 6: 34-39.PubMed
42.
Schröder C, Pfeiffer S, Wu G, Zorn GL, Ding L, Allen C, Harrison RA, White DJ, Azimzadeh AM, Pierson RN: Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood. J Heart Lung Transplant 2003, 22: 1365-1375.PubMedCrossRef
43.
Hecker JM, Lorenz R, Appiah R, Vangerow B, Loss M, Kunz R, Schmidtko J, Mengel M, Klempnauer J, Piepenbrock S, Dickneite G, Neidhardt H, Rückoldt H, Winkler M: C1-inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplantation. Transplantation 2002, 73: 688-694.PubMedCrossRef
44.
Hecker JM, Loss M, Klempnauer J, Winkler M: C1-inhibitor for therapy and prophylaxis of acute vascular rejection of porcine kidneys in cynomolgus monkeys. Transplant Proc 2002, 34: 2382.PubMedCrossRef
45.
Radke A, Mottaghy K, Goldmann C, Khorram-Sefat R, Kovacs B, Janssen A, Klosterhalfen B, Hafemann B, Pallua N, Kirschfi nk M: C1 inhibitor prevents capillary leakage after thermal trauma. Crit Care Med 2000, 28: 3224-3232.PubMedCrossRef
46.
Zwahlen A, Nydegger UE, Vaudaux P, Lambert PH, Waldvogel FA: Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J Infect Dis 1982, 145: 635-646.PubMedCrossRef
47.
Zwijnenburg PJ, van der Poll T, Florquin S, Polfliet MM, van den Berg TK, Dijkstra CD, Roord JJ, Hack CE, van Furth AM: C1 inhibitor treatment improves host defense in pneumococcal meningitis in rats and mice. J Infect Dis 2007, 196: 115-123.PubMedCrossRef
48.
Charneski L, Patel PN: Eculizumab in paroxysmal nocturnal haemoglobinuria. Drugs 2008, 68: 1341-1346.PubMedCrossRef
49.
Hack CE, Voerman HJ, Eisele B, Keinecke HO, Nuijens JH, Eerenberg AJ, Ogilvie A, Strack van Schijndel RJ, Delvos U, Thijs LG: C1-esterase inhibitor substitution in sepsis. Lancet 1992, 339: 378.PubMedCrossRef
50.
Hack CE, Ogilvie AC, Eisele B, Jansen PM, Wagstaff J, Thijs LG: Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy. Prog Clin Biol Res 1994, 388: 335-357.PubMed
51.
Caliezi C, Zeerleder S, Redondo M, Regli B, Rothen HU, Zürcher-Zenklusen R, Rieben R, Devay J, Hack CE, Lämmle B, Wuillemin WA: C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction. Crit Care Med 2002, 30: 1722-1728.PubMedCrossRef
52.
Zeerleder S, Caliezi C, van Mierlo G, Eerenberg-Belmer A, Sulzer I, Hack CE, Wuillemin WA: Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis. Clin Diagn Lab Immunol 2003, 10: 529-535.PubMedPubMedCentral
53.
Lazareva NB, Igonin AA: [Safety and efficacy of purified human C1-esterase inhibitor in the treatment of patients with sepsis]. Antibiot Khimioter 2009, 54: 42-46.PubMed
54.
Tapisiz A, Ergenekon E, Oktem M, Koc E, Okumus N, Zenciroğlu A, Atalay Y: C1 inhibitor level on neonatal sepsis and its relations with clinical findings. Paediatr Child Health 2010, 46: 121-124.CrossRef
55.
Bauernschmitt R, Bohrer H, Hagl S: Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA. Intensive Care Med 1998, 24: 635-638.PubMedCrossRef
56.
de Zwaan C, Kleine AH, Diris JH, Glatz JF, Wellens HJ, Strengers PF, Tissing M, Hack CE, van Dieijen-Visser MP, Hermens WT: Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. Eur Heart J 2002, 23: 1670-1677.PubMedCrossRef
57.
Thielmann M, Marggraf G, Neuhäuser M, Forkel J, Herold U, Kamler M, Massoudy P, Jakob H: Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction. Eur J Cardiothorac Surg 2006, 30: 285-293.PubMedCrossRef
58.
Fattouch K, Bianco G, Speziale G, Sampognaro R, Lavalle C, Guccione F, Dioguardi P, Ruvolo G: Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study. Eur J Cardiothorac Surg 2007, 32: 326-332.PubMedCrossRef
59.
Nurnberger W, Heying R, Burdach S, Gobel U: C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol 1997, 75: 95-101.PubMedCrossRef
60.
Strüber M, Hagl C, Hirt SW, Cremer J, Harringer W, Haverich A: C1-esterase inhibitor in graft failure after lung transplantation. Intensive Care Med 1999, 25: 1315-1318.PubMedCrossRef
61.
Kowal-Vern A, Walenga JM, Sharp-Pucci M, Hoppensteadt D, Gamelli RL: Postburn edema and related changes in interleukin-2, leukocytes, platelet activation, endothelin-1, and C1 esterase inhibitor. J Burn Care Rehabil 1997, 18: 99-103.PubMedCrossRef
62.
63.
Guo RF, Ward PA: C5a, a therapeutic target in sepsis. Recent Pat Antiinfect Drug Discov 2006, 1: 57-65.PubMedCrossRef
64.
Drug Commission of the German Medical Profession: Serious Thrombogenesis Following Berinert HS Dtsch Arztebl 2000., 97: A-1016/B-864/C-812
65.
Temiño VM, Peebles RS Jr: The spectrum and treatment of angioedema. Am J Med 2008, 121: 282-286.PubMedCrossRef
66.
Lou J, Lucas R, Grau GE: Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev 2001, 14: 810-820.PubMedPubMedCentralCrossRef
67.
Levinson WE: Review of Medical Microbiology and Immunology. 9th edition. New York: McGraw-Hill Medical; 2006.
Metadaten
Titel
Bench-to-bedside review: The role of C1-esterase inhibitor in sepsis and other critical illnesses
verfasst von
Mervyn Singer
Annie M Jones
Publikationsdatum
01.02.2011
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 1/2011
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9304

Weitere Artikel der Ausgabe 1/2011

Critical Care 1/2011 Zur Ausgabe

Research

Cardiac filling volumes versus pressures for predicting fluid responsiveness after cardiovascular surgery: the role of systolic cardiac function

Research

Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study

Research

Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure

Research

Medical pre-hospital management reduces mortality in severe blunt trauma: a prospective epidemiological study

Research

Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study

Research

Uncalibrated pulse power analysis fails to reliably measure cardiac output in patients undergoing coronary artery bypass surgery

Neu im Fachgebiet AINS

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

11.04.2024 | Rückenschmerzen | Nachrichten

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

08.04.2024 | Andrologie | Nachrichten

Wie toxische Männlichkeit der Gesundheit von Männern schadet
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren